Patents by Inventor Andrew Belch

Andrew Belch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer monitoring and therapeutics
    Patent number: 7504212
    Abstract: Provided for are three novel isoenzyme variants of the human Hyaluronan Synthase gene, HAS1Va, HAS1Vb, and HAS1Vc. Also provided is a method for assessing disease, or susceptibility to disease, in a patient; in which a cell or sample of a cell population is mixed with at least one compound which specifically binds to HAS1Va, HAS1Vb, HAS1Vc or HAS2 isoenzyme or isoenzyme variant genomic mRNA transcript or products arising therefrom; and methods of treatment.
    Type: Grant
    Filed: September 25, 2003
    Date of Patent: March 17, 2009
    Assignee: Governors of the University of Alberta
    Inventors: Linda Pilarski, Sophia Adamia, Andrew Belch, Tony Reiman, Mary Hay
  • Cancer monitoring and therapeutics
    Publication number: 20050003368
    Abstract: Provided for are three novel isoenzyme variants of the human Hyaluronan Synthase gene, HAS1Va, HAS1Vb, and HAS1Vc. Also provided is a method for assessing disease, or susceptibility to disease, in a patient; in which a cell or sample of a cell population is mixed with at least one compound which specifically binds to HAS1Va, HAS1Vb, HAS1Vc or HAS2 isoenzyme or isoenzyme variant genomic mRNA transcript or products arising therefrom; and methods of treatment.
    Type: Application
    Filed: September 25, 2003
    Publication date: January 6, 2005
    Inventors: Linda Pilarski, Sophia Adamia, Andrew Belch, Tony Reiman, Mary Hay